Angela Toss
Papers
2
Total Citations
6
H-Index
2
About
Angela Toss is a clinical researcher whose work sits at the intersection of genomics, hereditary cancer genetics, and precision oncology. Her research focuses on the application of Next Generation Sequencing (NGS) technologies to identify mutations in hereditary cancer genes, with the goal of enabling personalized prevention strategies for individuals at elevated cancer risk. Toss has made notable contributions to the translation of cutting-edge genomic tools into routine clinical practice, most prominently through her investigations into automated capture-based NGS workflows. Her landmark 2021 study documenting the experience of over one thousand patients represents a significant milestone in validating the scalability and uniformity of such workflows within real-world clinical settings, demonstrating that robust, high-throughput genetic screening can be reliably integrated into standard care frameworks. This work, which has garnered citations from the broader oncogenomics community, addresses a critical challenge in the field: balancing the accessibility of amplicon-based library construction with the greater enrichment uniformity offered by capture-based approaches. For students and researchers interested in hereditary cancer risk assessment, clinical genomics implementation, or NGS methodology, Toss's contributions offer valuable insights into bridging laboratory innovation with patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2